Skip to content
Open access

Seroprevalence and the determinants of lumpy skin disease virus (LSDV) in cattle reared under smallholder production systems in northwestern Bangladesh.

Oct 2026 · Preventive Veterinary Medicine · Vol 257, pp. 107045 · 0 citations · 48 references
Medicine

Abstract

Lumpy skin disease (LSD) is a vector-borne transboundary disease that causes substantial productivity losses in cattle. This study was undertaken to determine the seroprevalence of LSD and the associated determinants of non-vaccinated cattle reared in smallholder production systems of northwestern Bangladesh. A cross-sectional study was conducted from November 2024 to January 2025 covering ten districts where a total of 450 non-vaccinated cattle were sampled across 100 smallholder farms. Sera were tested for LSDV-specific antibodies using a commercial ELISA kit test and thereafter risk-factors determined using a structured questionnaire. The overall on-farm seroprevalence was 95% (95% CI: 88.80-97.80). Previous history of clinical LSD on the animals was the strongest predictor of seropositivity 89.3% (OR = 8.1, p = <0.001, 95% CI = 3.44-19.1). Age was also strongly associated with seropositivity (p < 0.001), with at 47.7% (95% CI: 40.3-55.1) among cattle aged ≤ 1 year to 78.6% (95% CI = 70.8-84.8) among those aged > 3 years. A significant difference in seroprevalence was similarly observed in cows 66.8% (95% CI = 61.6-71.6) compared to bulls 52.7% (OR = 0.56; p = <0.001, 95% CI = 0.35-0.87). Indigenous cattle recorded a lower seropositivity of 56.8% (95% CI = 50.2-63.2) than Holstein-Friesian crossbreds 71.2% (OR = 0.43, p = <0.001, 95% CI = 0.31-0.58). It is concluded that LSDV exposure was widespread among cattle of the northwestern districts of Bangladesh and a history of previous infection with LSD was as the main determinant of seropositivity. Risk-based control strategies such as the vaccination of young cattle, control of vectors and producer training need to be considered.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.